Search results
Results From The WOW.Com Content Network
[2] [3] It is used to treat abdominal distension following some surgeries, and in stomach roentgenography. [3] Vasopressin is a hormone that affects the kidneys and reduces urine flow. [4] Side effects may include stomach ache, vertigo, pale skin, flatulence, headache, or tremor. [3] [4] It is available as a generic medication. [5]
Vasopressin is used to manage anti-diuretic hormone deficiency. Vasopressin is used to treat diabetes insipidus related to low levels of antidiuretic hormone. It is available as Pressyn. [53] Vasopressin has off-label uses and is used in the treatment of vasodilatory shock, gastrointestinal bleeding, ventricular tachycardia and ventricular ...
Central diabetes insipidus can be caused by various congenital or acquired lesions, and when the cause is unknown, it is classified as idiopathic. The water deprivation test (WDT) is a commonly used test for diabetes insipidus , a two-step process involving parenteral desmopressin administration after an initial 8-hour water fast.
The vasopressin receptor 2 blocker tolvaptan may also be used. [2] The presence of cerebral edema, or other moderate to severe symptoms, may necessitate intravenous hypertonic saline administration with close monitoring of the serum sodium levels to avoid overcorrection. [2]
The major endogenous antidiuretics are antidiuretic hormone (ADH; also called vasopressin) and oxytocin. Both of those are also used exogenously as medications in people whose bodies need extra help with fluid balance via suppression of diuresis.
“The question arises of whether we should consider use of hormone replacement therapy, either to prevent osteoarthritis or try to treat it if it occurs in post menopausal populations. This would ...
It’s also used to treat some vasomotor symptoms (i.e., symptoms caused by fluctuations in the diameter of the blood vessels) that can develop during menopause, such as hot flashes, night sweats ...
Vasopressin comes as the second-line agent. [24] However, high-dose therapy is linked to excessive coronary, splanchnic vasoconstriction, and hypercoagulation. [6] Excessive vasoconstriction can cause cardiac output reduction or even fatal heart complication particularly in those with weak myocardial function. [6] [4] [28] [29]